\-\ Texto\\:\\ \ \(0\)\
\-\ negtive\ \(1\)\
\-\ biopsy\\ followed\\ by\\ radiation\\ therapy\ \(1\)\
\-\ \\â\\€\\¢\\ mass\\ in\\ the\\ left\\ parietal\\ lobe\\.\ \(0\)\
\-\ \\â\\€\\¢\\ effacement\\ of\\ sulci\\ and\\ compression\\ of\\ ventricle\ \(0\)\
\-\ \\â\\€\\¢\\ no\\ enhancement\\ after\\ gadolinium\ \(0\)\
\-\ \\â\\€\\¢\\ abnormal\\ high\\ signal\\ on\\ flair\\ and\\ t2\\ images\ \(0\)\
\-\ astrocytoma\\,\\ diffuse\\,\\ who\\ grade\\ 2\ \(0\)\
\-\ \\â\\€\\¢\\ ganglioglioma\ \(1\)\
\-\ \\â\\€\\¢\\ dnet\ \(0\)\
\-\ \\â\\€\\¢\\ tumefactive\\ demyelination\ \(0\)\
\-\ \\â\\€\\¢\\ oligodendroglioma\ \(1\)\
\-\ \\â\\€\\¢\\ astrocytoma\\ \\-\\ low\\ grade\ \(0\)\
\-\ 39\\ year\\ old\\ wman\\ with\\ worsening\\ headaches\\ over\\ past\\ three\\ months\\.\\ right\\-sided\\ paresthesias\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ negtive\\:\\ 0\\.28086198247368466\ \(0\)\
\-\ wman\\:\\ 0\\.28086198247368466\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.26516137217794095\ \(0\)\
\-\ grade\\:\\ 0\\.252578753586842\ \(0\)\
\-\ demyelination\\:\\ 0\\.20435726282082248\ \(0\)\
\-\ paresthesias\\:\\ 0\\.20189292682198634\ \(0\)\
\-\ tumefactive\\:\\ 0\\.19961130806011199\ \(0\)\
\-\ dnet\\:\\ 0\\.19455278448208488\ \(0\)\
\-\ ganglioglioma\\:\\ 0\\.1843271263319878\ \(0\)\
\-\ oligodendroglioma\\:\\ 0\\.1843271263319878\ \(0\)\
\-\ sulci\\:\\ 0\\.18055247496580307\ \(0\)\
\-\ effacement\\:\\ 0\\.17415972319276835\ \(0\)\
\-\ flair\\:\\ 0\\.1494075447708822\ \(0\)\
\-\ gadolinium\\:\\ 0\\.1463364529052763\ \(0\)\
\-\ 39\\:\\ 0\\.14594918032648854\ \(0\)\
\-\ parietal\\:\\ 0\\.14181400376544298\ \(0\)\
\-\ worsening\\:\\ 0\\.13411400363728593\ \(0\)\
\-\ headaches\\:\\ 0\\.13100148024334\ \(0\)\
\-\ ventricle\\:\\ 0\\.1292746109776544\ \(0\)\
\-\ compression\\:\\ 0\\.12861010106552329\ \(0\)\
\-\ biopsy\\:\\ 0\\.12310658840724979\ \(0\)\
\-\ followed\\:\\ 0\\.11859716052610013\ \(0\)\
\-\ three\\:\\ 0\\.11789296241522915\ \(0\)\
\-\ radiation\\:\\ 0\\.11638345597719817\ \(0\)\
\-\ past\\:\\ 0\\.11431830013677576\ \(0\)\
\-\ diffuse\\:\\ 0\\.11013836762421857\ \(0\)\
\-\ abnormal\\:\\ 0\\.10551291307237451\ \(0\)\
\-\ months\\:\\ 0\\.10222773086555571\ \(0\)\
\-\ lobe\\:\\ 0\\.10149246573521377\ \(0\)\
\-\ enhancement\\:\\ 0\\.10108646735867997\ \(0\)\
\-\ t2\\:\\ 0\\.10104168514851067\ \(0\)\
\-\ therapy\\:\\ 0\\.10090772802320092\ \(0\)\
\-\ low\\:\\ 0\\.10077435121938673\ \(0\)\
\-\ high\\:\\ 0\\.0998135203222488\ \(0\)\
\-\ signal\\:\\ 0\\.09955659729528643\ \(0\)\
\-\ who\\:\\ 0\\.09934412050949622\ \(0\)\
\-\ over\\:\\ 0\\.09765500353990617\ \(0\)\
\-\ after\\:\\ 0\\.08519837655155398\ \(0\)\
\-\ images\\:\\ 0\\.08123807388755021\ \(0\)\
\-\ by\\:\\ 0\\.07458039451078034\ \(0\)\
\-\ and\\:\\ 0\\.0725813503371545\ \(0\)\
\-\ of\\:\\ 0\\.06873791703783172\ \(0\)\
\-\ mass\\:\\ 0\\.06708391208270524\ \(0\)\
\-\ left\\:\\ 0\\.0599093843100442\ \(0\)\
\-\ no\\:\\ 0\\.057111124278075284\ \(0\)\
\-\ year\\:\\ 0\\.05412404656610457\ \(0\)\
\-\ on\\:\\ 0\\.05304164629502413\ \(0\)\
\-\ old\\:\\ 0\\.05197782020713028\ \(0\)\
\-\ in\\:\\ 0\\.04368970283707806\ \(0\)\
\-\ the\\:\\ 0\\.035043473082082506\ \(0\)\
\-\ with\\:\\ 0\\.034389493963441244\ \(0\)\
